Iron deficiency defined by TSAT <20% was associated with increased all-cause mortality in non-anaemic patients with new-onset chronic heart failure (HR 1.57; 95% CI 1.30-1.89).
Cohort (n=9,477)
Yes
Does the definition of iron deficiency impact its prognostic value for mortality and hospitalization in patients with new-onset chronic heart failure?
9,477 patients with new-onset chronic heart failure registered in the Danish Heart Failure Registry from April 2003 to December 2019.
Presence of iron deficiency defined by four criteria: ESC guidelines (ferritin <100 ng/mL or ferritin 100-299 ng/mL and TSAT <20%), ferritin <100 ng/mL, TSAT < 20%, and serum iron ≤13 μmol/L.
Absence of iron deficiency according to the respective definitions.
All-cause mortality, cardiovascular mortality, and first hospitalization for heart failure.hard clinical
Iron deficiency defined by TSAT < 20% or serum iron ≤13 μmol/L provides better prognostic value for mortality in new-onset chronic heart failure regardless of anaemia status compared to the current ESC guideline definition.
Effect estimate: HR 1.57 (95% CI 1.30-1.89)
AIMS: Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all-cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new-onset chronic HF. METHODS: In this nationwide registry-based cohort, we explored four definitions of ID: the current European Society of Cardiology (ESC) guidelines ferritin 13 μmol/L and TSAT > 20%. Regardless of anaemia status, ID defined by TSAT < 20% or serum iron ≤13 μmol/L was associated with all-cause mortality [non-anaemic, hazard ratio (HR): 1.57, 95% confidence interval (CI): 1.30-1.89 and HR: 1.47, 95% CI: 1.24-1.73; anaemic, HR: 1.22, 95% CI: 1.07-1.38 and HR: 1.25, 95% CI: 1.09-1.44, respectively and cardiovascular mortality (non-anaemic, HR: 2.21, 95% CI: 1.59-3.06 and HR: 1.47, 95% CI: 1.12-1.95; anaemic, HR: 1.37, 95% CI: 1.11-1.69 and HR: 1.28, 95% CI: 1.02-1.61, respectively), as well as increased risk of first hospitalization for HF (non-anaemic, HR: 1.28, 95% CI: 1.09-1.1.50 and HR: 1.27, 95% CI: 1.10-1.46; anaemic, HR: 1.25, 95% CI: 1.08-1.44 and HR: 1.22, 95% CI: 1.05-1.42, respectively). ID defined by ESC guidelines was associated with all-cause and cardiovascular mortality only in non-anaemic patients (HR: 1.41, 95% CI: 1.18-1.1.70 and HR: 1.58, 95% CI: 1.18-2.12.). Furthermore, the ESC guideline definition was associated with increased risk of first hospitalization for HF, regardless of anaemia status (non-anaemic, HR: 1.26, 95% CI: 1.08-1.1.47; anaemic, HR: 1.34, 95% CI: 1.17-1.53). CONCLUSIONS: ID, when defined by TSAT < 20% or serum iron ≤13 μmol/L, is associated with increased risk of all-cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new-onset chronic HF, regardless of anaemia status. Conversely, ID defined as ESC guidelines is associated with all-cause and cardiovascular mortality only in non-anaemic patients.
Building similarity graph...
Analyzing shared references across papers
Loading...
Abdullahi Ahmed Mohamed
University of Alberta
Daniel Mølager Christensen
Heart Failure & Transplant
Milan Mohammad
University of Copenhagen
ESC Heart Failure
Harvard University
Brigham and Women's Hospital
University of Copenhagen
Building similarity graph...
Analyzing shared references across papers
Loading...
Mohamed et al. (Wed,) conducted a cohort in New-onset chronic heart failure (n=9,477). Iron deficiency (TSAT < 20%, serum iron ≤13 μmol/L, or ESC guidelines) vs. No iron deficiency was evaluated on All-cause mortality (TSAT < 20% in non-anaemic patients) (HR 1.57, 95% CI 1.30-1.89). Iron deficiency defined by TSAT <20% was associated with increased all-cause mortality in non-anaemic patients with new-onset chronic heart failure (HR 1.57; 95% CI 1.30-1.89).
synapsesocial.com/papers/6a1b7601664f78119642e22f — DOI: https://doi.org/10.1002/ehf2.15149